Open Access

Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer

  • Liang Feng1, 2,
  • Hang-Ping Yao1, 2,
  • Sharad Sharma2,
  • Yong-Qing Zhou3,
  • Jianwei Zhou4,
  • Ruiwen Zhang5 and
  • Ming-Hai Wang1, 2Email author
Contributed equally
Journal of Experimental & Clinical Cancer Research201635:95

https://doi.org/10.1186/s13046-016-0364-5

Received: 25 May 2016

Accepted: 25 May 2016

Published: 17 June 2016

The original article was published in Journal of Experimental & Clinical Cancer Research 2016 35:70

Erratum

Unfortunately, the original version of this article [1] contained an error. The name of one of the authors, Sharad Sharma, was not included in the author list.

The correct author list and the new “Authors’ contributions” section have been correctly included in full in this erratum and updated in the original article.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
State Key Laboratory for Diagnosis & Treatment of Infectious Diseases and Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases, First Hospital of Zhejiang University School of Medicine
(2)
Department of Biomedical Sciences, Texas Tech University Health Sciences Center School of Pharmacy
(3)
Department of Neurosurgery, First Hospital of Zhejiang University School of Medicine
(4)
Department of Molecular Cell Biology & Toxicology, Nanjing Medical University School of Public Health
(5)
Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center School of Pharmacy

References

  1. Feng L, Yao HP, Sharma S, Zhou YQ, Zhou J, Zhang R, et al. Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer. J Exp Clin Cancer Res. 2016;35(1):70. doi:10.1186/s13046-016-0347-6.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement